GABRIELLI, GIULIA
 Distribuzione geografica
Continente #
AS - Asia 243
EU - Europa 67
NA - Nord America 47
SA - Sud America 32
AF - Africa 10
OC - Oceania 2
Totale 401
Nazione #
CN - Cina 91
SG - Singapore 63
US - Stati Uniti d'America 45
IT - Italia 36
VN - Vietnam 30
BR - Brasile 28
HK - Hong Kong 23
KR - Corea 21
NL - Olanda 12
IN - India 8
DE - Germania 7
JP - Giappone 6
SC - Seychelles 5
CI - Costa d'Avorio 4
FI - Finlandia 4
AR - Argentina 2
AT - Austria 2
AU - Australia 2
FR - Francia 2
GB - Regno Unito 2
PY - Paraguay 2
CA - Canada 1
ID - Indonesia 1
MX - Messico 1
PL - Polonia 1
SE - Svezia 1
ZA - Sudafrica 1
Totale 401
Città #
Hefei 52
Singapore 44
Ashburn 25
Hong Kong 23
Seoul 21
Bologna 16
Hanoi 9
Ho Chi Minh City 8
Milan 8
Beijing 6
Bengaluru 6
Tokyo 6
Abidjan 4
Lappeenranta 4
Verona 4
Dallas 3
Mirandola 3
São Paulo 3
Tongling 3
Adelaide 2
Biên Hòa 2
Buffalo 2
New York 2
Novara 2
Redondo Beach 2
Shenzhen 2
Taizhou 2
Amargosa 1
Annapolis 1
Araxá 1
Asunción 1
Belo Horizonte 1
Boardman 1
Boituva 1
Brasília 1
Bắc Giang 1
Bắc Ninh 1
Camden 1
Cape Town 1
Carapicuíba 1
Chicago 1
Cotia 1
Criciúma 1
Da Nang 1
Denver 1
Divino 1
Düsseldorf 1
Falkenstein 1
Formosa 1
Frankfurt am Main 1
Guangzhou 1
Guarulhos 1
Haiphong 1
Houston 1
Hyderabad 1
Igarassu 1
Iguaba Grande 1
Itaquaquecetuba 1
Juazeiro 1
Limeira 1
Linhares 1
London 1
Macapá 1
Maria da Fé 1
Mariano Moreno 1
Mexico City 1
Munich 1
Nam Định 1
New Delhi 1
Nova Brasilândia d'Oeste 1
Nova Lima 1
Nuremberg 1
Osnabrück 1
Palmas 1
Parauapebas 1
Quảng Ngãi 1
Quận Hai 1
Quận Một 1
Quận Năm 1
Quận Sáu 1
Salvador 1
San Jose 1
San Lorenzo 1
Stockholm 1
São Bernardo do Campo 1
Thái Bình 1
Torres 1
Warsaw 1
Whitby 1
Xi'an 1
Xingtai 1
Totale 328
Nome #
Long-term efficacy of immune checkpoint inhibitors for relapsed primary mediastinal B-cell lymphoma: a real-world study 126
Efficacy and Safety of Frontline Single‐Agent Rituximab in Extranodal Marginal Zone Lymphoma 123
Further strategies after immune checkpoint inhibitors in relapsed/refractory Hodgkin lymphoma: salvage treatments and consolidation with transplantation, experience in daily clinical practice 105
SARS-CoV-2 infection does not affect the outcome of patients with relapsed/refractory large B-cell lymphoma treated with CAR T-cell therapy 60
Totale 414
Categoria #
all - tutte 688
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 688


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2024/2025136 0 0 0 0 3 8 9 4 9 25 8 70
2025/2026278 64 78 52 45 29 10 0 0 0 0 0 0
Totale 414